Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary
Open Access
- 29 August 2015
- journal article
- Published by Medknow in Journal of Dermatology & Dermatologic Surgery
- Vol. 20 (1), 19-26
- https://doi.org/10.1016/j.jdds.2015.07.004
Abstract
Background: Patients with psoriasis (PsO) suffer from a variety of symptoms. Tools are needed to assess PsO symptoms and signs from the patient’s perspective. Objective: To develop a patient-reported outcome (PRO) measure to assess symptoms and signs in individuals with moderate-to-severe PsO. Methods: Face-to-face concept elicitation interviews were conducted with 20 subjects with moderate-to-severe plaque PsO. Results from the interviews, a literature review, and clinical input informed the development of the draft Psoriasis Symptoms and Signs Diary (PSSD). Three waves of face-to-face cognitive interviews (n = 19) were conducted to evaluate the clarity and relevance of the PSSD. Additional interviews (n = 5) were conducted to confirm its content. Results: The PSSD assesses severity of 5 symptoms (itch, pain, stinging, burning, skin tightness) and 6 observable signs (skin dryness, cracking, scaling, shedding or flaking, redness, bleeding) using 0–10 numerical ratings. Two versions with different recall periods (24 h and past 7 days) were developed. PsO patients found the PSSD to be clear and relevant. Limitations: The sample had limited racial diversity. Conclusion: The PSSD, developed according to the Food and Drug Administration PRO Guidance, assesses severity of symptoms and signs commonly associated with plaque PsO. Its measurement properties are currently being evaluated.This publication has 24 references indexed in Scilit:
- Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011PLOS ONE, 2012
- Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social LifeActa Dermato-Venereologica, 2012
- What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literatureJournal of the European Academy of Dermatology and Venereology, 2010
- The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groupsHealth and Quality of Life Outcomes, 2009
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004Journal of the American Academy of Dermatology, 2009
- A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global AssessmentBritish Journal of Dermatology, 2006
- Determinants of quality of life in patients with psoriasis: A study from the US populationJournal of the American Academy of Dermatology, 2004
- The impact of psoriasis on quality of lifeBritish Journal of Dermatology, 2001
- Skindex, a Quality-of-Life Measure for Patients with Skin Disease: Reliability, Validity, and ResponsivenessJournal of Investigative Dermatology, 1996
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994